Comparison of two doses of drug dexmedetomidine via inhalation through oral mask route for sleep and pain in children

Randomized comparison between efficacy of two doses of nebulized dexmedetomidine as a premedicant in pediatric patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010276

Enrollment

Registered

2017-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA 1 and 2

Interventions

Intervention1: Group A 2 mcg/kg dexmedetomidine deluted with normal saline: Total volume 3 mlcontaining 2mcg/kg demedetomidine in nebulizer mask chamber once 30 -40 minutes before shifting the patient

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients going for surgery under caudal anaesthesia

Exclusion criteria

Exclusion criteria: ASA 3 and 4 patients patient having history of cardiac disease,asthma,seizue, prematurity,development delay,mantal retardation,drug allergy history,congenital anomaly of sacrum

Design outcomes

Primary

Measure	Time frame
Sepration anxiety scoreTimepoint: Sepration anxiety score at 30 min after end of nebulization	—

Secondary

Measure	Time frame
Mask acceptance score,Time of need of first rescue analgesia, Saftey profile in terms of hemodynamicsTimepoint: Duringinduction, Need of first rescue analgesia when patient had pain according to FLACC score postoperative	—

Countries

India

Contacts

Public ContactDr Anupriya

Shri Satya Sai Medical College and Research institue

garg.anupriya@gmail.com044-27440700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026